Long-term anticoagulation is associated with type II endoleaks and failure of sac regression after endovascular aneurysm repair
- 25 February 2022
- journal article
- conference paper
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 76 (2) , 437-444.e2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Society for Vascular Surgery Vascular Quality InitiativeJournal of Vascular Surgery, 2012
- Long-term follow-up of type II endoleak embolization reveals the need for close surveillanceJournal of Vascular Surgery, 2012
- 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline)JACC, 2011
- The effect of warfarin therapy on endoleak development after endovascular aneurysm repair (EVAR) of the abdominal aortaJournal of Vascular Surgery, 2010
- Endovascular versus Open Repair of Abdominal Aortic AneurysmNew England Journal of Medicine, 2010
- An 8-year experience with type II endoleaks: Natural history suggests selective intervention is a safe approachJournal of Vascular Surgery, 2006
- Does Chronic Oral Anticoagulation With Warfarin Affect Durability of Endovascular Aortic Aneurysm Exclusion in a Midterm Follow-up?Journal of Endovascular Therapy, 2005
- A Randomized Trial Comparing Conventional and Endovascular Repair of Abdominal Aortic AneurysmsNew England Journal of Medicine, 2004
- What is the significance of endoleaks and endotensionSurgical Clinics of North America, 2004
- Relationship of age, gender, race, and body size to infrarenal aortic diameterJournal of Vascular Surgery, 1997